Sight for Life
Personalized Flow. IOP Control.
Designed to be the first-of-its-kind treatment that allows maximum IOP reduction for patients with moderate to severe glaucoma.
Personalized flow for evolving patient needs
Intends to address gaps in treatments for patients with moderate to severe glaucoma
Approach provides predictable outcomes
Sep. 6, 2023
First-of-its-kind titratable glaucoma therapy system aims to optimize reduction of intraocular pressure (IOP)
Jun. 26, 2023
Myra Vision, a Shifamed Portfolio Company, Closes $25M in Series B Financing
Funding to support product development and initiate clinical experience of first-of-its-kind surgical treatment for patients with moderate to advanced glaucoma